Odyssean, LLC
CIK 2092853
13F filing for Q2 2026・No. 3,457
- Holdings
- US$614.88M
- Quarter change
- +US$340.96M
- Entries
- 485
- Net bought (estimate)
- +US$294.97M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 166
- Sold out 99
- Cut 29
- Added 188
- Corporate actions 0
- Unchanged 102
Largest holdings
485 stocks worth US$614.88M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| RAREULTRAGENYX PHARMACEUTICAL INCOM | Added | 122,087 | US$4.08M | 0.66% |
| KYMERA THERAPEUTICS INCCOM | Added | 34,485 | US$3.95M | 0.64% |
| IDEAYA BIOSCIENCES INCCOM | Added | 102,582 | US$3.82M | 0.62% |
| PCVXVAXCYTE INCCOM | Added | 62,638 | US$3.64M | 0.59% |
| AFRMAFFIRM HLDGS INCCOM CL A | Added | 43,968 | US$3.59M | 0.58% |
| CELLDEX THERAPEUTICS INC NEWCOM NEW | New | 95,069 | US$3.54M | 0.58% |
| LOARLOAR HOLDINGS INCCOM SHS | Added | 43,660 | US$3.52M | 0.57% |
| MIRUM PHARMACEUTICALS INCCOM | Added | 29,924 | US$3.5M | 0.57% |
| DASHDOORDASH INCCL A | New | 18,915 | US$3.49M | 0.57% |
| KRYSKRYSTAL BIOTECH INCCOM | Added | 9,349 | US$3.47M | 0.57% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.